Design of a Multi-Mechanistic Triple Therapy to Overcome Biofilm-Associated Resistance in Pseudomonas aeruginosa
ISEF · 2026 Microbiology
Overview
Biofilm-mediated resistance is a major barrier to treating Pseudomonas aeruginosa infections. Biofilms are estimated to contribute to over 65% of microbial infections, allowing bacteria to persist despite antibiotics and host immune defenses and driving chronic, multidrug-resistant disease. This study investigates the relationship between biofilm formation and antimicrobial resistance (AMR) gene expression in P. aeruginosa and evaluates a triple-therapy strategy combining resveratrol, EDTA, and meropenem. Fifty clinical isolates were analyzed. Biofilm production was quantified using the crystal violet microtiter assay (OD550), antimicrobial susceptibility was assessed via VITEK-2, and key AMR genes (mexB, ampC, gyrA, and oprD) were detected using PCR. Correlation analysis assessed the relationship between biofilm biomass and resistance gene prevalence. Chequerboard assays evaluated drug interactions using fractional inhibitory concentration indices (FICI). Results showed substantial variability in biofilm formation, with strong producers exceeding OD550 > 2.5. Multidrug resistance was widespread, supported by efflux pump, ß-lactamase, porin, and gyrase-associated genes. A positive correlation (r = 0.22) between biofilm biomass and AMR gene count suggests that stronger biofilm formation is linked to increased resistance potential. Chequerboard testing demonstrated synergistic interactions, with reduced effective concentrations and FICI values indicating greater efficacy than monotherapy. By targeting quorum sensing, matrix stability, and cell wall synthesis simultaneously, this strategy may improve outcomes and support more effective therapy for chronic and drug-resistant P. aeruginosa infections.
Awards (1)
- Missouri University of Science and Technology: Summer Camp scholarships (camp tuition and travel expenses, valued at up to $1,500) $1,500
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2023
Combating Pseudomonas Resistance: Cloning of the ampC Gene Encoding for Beta-Lactamase and Development of a Non-Toxic Allosteric Inhibitory Cocktail Therapy to Eradicate Pseudomonas aeruginosa
ISEF · 2021
Generating a Non-toxic, Multi-pathway Targeted Cocktail Treatment Composed of N- Acetylcysteine, Carvacrol, and DNase to Inhibit Pseudomonas Biofilm Proliferation in vitro
ISEF · 2022
Computational Analysis of the Cystic Fibrosis Lung Microbiome and Development of a Non-Toxic Quorum Quenching Cocktail Therapy To Inhibit Multispecies Biofilm Proliferation
ISEF · 2026
Antibiotic Combinations as an Alternative Strategy Against Bacterial Resistance in Pseudomonas aeruginosa and Staphylococcus aureus
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair